Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adaptive Biobehavioral Control (ABC) in a Closed-Loop System

NCT: NCT05610111 · COMPLETED

NCT IDNCT05610111
StatusCOMPLETED
Start Date2023-01-18
Completion2024-09-28
SponsorSue Brown (OTHER)
First posted
Last updated

Brief Summary

This study is intended to test a Web-based Information Tool (WIT) software providing additional information regarding time in range, GMI, hypo- and hyperglycemia risks, variability tracker, daily glycemic profiles, and potential changes of insulin pump parameters, to users of a commercially available Closed-Loop Control (CLC) System (Control-IQ Technology).

Frequently Asked Questions

What is Adaptive Biobehavioral Control (ABC) in a Closed-Loop System?

Adaptive Biobehavioral Control (ABC) in a Closed-Loop System is a clinical trial registered under NCT05610111. Current status: COMPLETED.

What is the status of NCT05610111?

The current status of NCT05610111 (Adaptive Biobehavioral Control (ABC) in a Closed-Loop System) is: COMPLETED.

When did Adaptive Biobehavioral Control (ABC) in a Closed-Loop System start?

Adaptive Biobehavioral Control (ABC) in a Closed-Loop System started on 2023-01-18.

Related Devices

K201214t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K223213Tandem Mobi Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K232380t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K233044Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. K240309Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑